| Health / Medical Topics |
Dual PI3 Kinase/mTOR Inhibitor GDC-0980
An orally available agent targeting phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. PI3K/mTOR kinase inhibitor GDC-0980 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated in a PI3K-independent fashion. (NCI Thesaurus)
YOU MAY ALSO LIKE
A dosing unit equal to the amount of active ingredient(s) in a product containing two individual units.
An oral small molecule inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (InsR) tyrosine kinases with potential antineoplastic…
An imaging test that measures bone density (the amount of bone mineral contained in a certain volume of bone) by passing x-rays…
A person with dual diagnosis has both a mental disorder and an alcohol or drug problem. These conditions occur together frequently. In…
A pump system with two enclosed reservoirs, designed to deliver various concentrations of intravenous contrast media.
A heart pacemaker with the capability of monitoring and stimulating both the atria and/or the ventricles when necessary.
